DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 134 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $12,497,000 | +295.5% | 1,709,541 | +395.0% | 1.62% | +222.2% |
| Q4 2018 | $3,160,000 | -53.4% | 345,339 | -36.8% | 0.50% | -53.9% |
| Q3 2018 | $6,774,000 | -19.1% | 546,265 | -0.5% | 1.09% | -16.1% |
| Q2 2018 | $8,369,000 | -7.1% | 548,777 | +21.0% | 1.30% | -34.1% |
| Q1 2018 | $9,005,000 | +15.9% | 453,634 | +9.2% | 1.98% | -7.2% |
| Q4 2017 | $7,771,000 | +32.0% | 415,573 | +51.7% | 2.13% | +14.3% |
| Q3 2017 | $5,889,000 | – | 273,930 | – | 1.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
| DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
| Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
| PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
| Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
| Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
| Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
| Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |